Table 7.
The Different of Laboratory Values at Baseline and Follow up Period in the As-Treated Population on each Treatment Group
| Different of value (at baseline and follow up) | Curcumin | Placebo | p-value |
|---|---|---|---|
| mean, (SEM*) | mean, (SEM*) | ||
| Hematologic | |||
| Hemoglobin (gram per deciliter) | -0.79 (0.46) | -0.14 (0.37) | 0.274 |
| White blood cell count **(per cubic millimeter) | +664.71(2012.79) | +951.88 (2006.05) | 0.92 |
| Platelet count (per cubic millimeter) | -18705.88 (34106.32) | -14062.50 (40446.62) | 0.93 |
| Nonhematologic | |||
| Serum creatinine (milligram per deciliter) | +0.04 (0.06) | -0.14 (0.06) | 0.045*** |
| Serum total bilirubin (milligram per deciliter) | +0.09 (0.18) | +0.26 (0.30) | 0.622 |
| Serum aspartate aminotransferase (AST) (international units per liter) | +8.59 (10.27) | +3.13 (8.01) | 0.68 |
| Serum alanine aminotransferase (ALT) (international units per liter) | +13.12 (18.06) | +1.31 (5.82) | 0.549 |
| Serum albumin (gram per deciliter) | -0.26 (0.17) | -0.78 (0.35) | 0.186 |
*SEM, Standard Error of means; **Events were attributed to treatment by the investigator and are listed as indicated by the investigator on the case-report form. Although decreased or increased white blood cell count may reflect some condition such as post-chemotherapy or infection process. ***p-value less than 0.05 statistically significant